Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
zolbetuximab
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
zolbetuximab
Unique ID
C585662
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C585662
Entry Term(s)
IMAB-362
IMAB362
claudiximab
vyloy
zolbetuximab-clzb
Registry Numbers
TF5MPQ8WGY
Heading Mapped to
*Antibodies, Monoclonal
Frequency
11
Note
in Phase IIa trial 1/14 for treatment of advanced gastroesophageal cancer (clincaltrials.gov: NCT00909025)
Source
Int J Cancer. 2013 Feb 1;134(3):731-9
Date of Entry
2025/03/05
Revision Date
2025/02/18
Expand All
Collapse All
zolbetuximab
Preferred
Concept UI
M000655078
Registry Numbers
TF5MPQ8WGY
Terms
zolbetuximab
Preferred Term
Term UI
T000967374
Date
09/05/2019
LexicalTag
NON
ThesaurusID
zolbetuximab-clzb
Term UI
T001147211
Date
02/18/2025
LexicalTag
NON
ThesaurusID
NLM (2025)
claudiximab
Narrower
Concept UI
M0590488
Terms
claudiximab
Preferred Term
Term UI
T000939043
Date
01/12/2018
LexicalTag
NON
ThesaurusID
NLM (2017)
IMAB362
Narrower
Concept UI
M000640448
Terms
IMAB362
Preferred Term
Term UI
T853637
Date
01/16/2014
LexicalTag
LAB
ThesaurusID
NLM (2014)
IMAB-362
Term UI
T000967375
Date
09/05/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
vyloy
Narrower
Concept UI
M000768765
Terms
vyloy
Preferred Term
Term UI
T001147212
Date
02/18/2025
LexicalTag
TRD
ThesaurusID
NLM (2025)
page delivered in 0.004s